Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 3, 1996, Pages 314-323

  Chen, Husheng ^b   Fetscher, Charlotte ^a   Schäfers, Rafael F ^a   Wambach, Gerhard ^b   Philipp, Thomas ^a   Michel, Martin C ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Krankenhaus St Elisabeth   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

(1A) Adrenoceptor; Microvessel; Neuropeptide Y; Noradrenaline; Y1 NPY receptor

Indexed keywords

5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CHLOROETHYLCLONIDINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [18-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y1 RECEPTOR; NITRENDIPINE; NORADRENALIN; PEPTIDE YY; PRAZOSIN; RECEPTOR SUBTYPE; TAMSULOSIN; YOHIMBINE;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; MESENTERY BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; RAT; RECEPTOR AFFINITY; RESISTANCE BLOOD VESSEL; VASOCONSTRICTION;

ANIMALS; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; LETHAL DOSE 50; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NEUROPEPTIDE Y; NOREPINEPHRINE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, NEUROPEPTIDE Y; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030001939     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00168634     Document Type: Article

References (48)

1. 1-adrenoceptor stimulation in rat isolated mesenteric arterioles. Br J Pharmacol 99:389-395
2. Andriantsitohaina R, Andre P, Stoclet J-C (1990) Pertussis toxin abolishes the effect of neuropeptide Y on rat resistance arteriole contraction. Am J Physiol 259:H1427-H1432
3. Andriantsitohaina R, Bian K, Stoclet J-C, Bukoski RD (1993) Neuropeptide Y increases force development through a mechanism that involves calcium entry in resistance arteries. J Vasc Res 30:309-314
4. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
5. 1B-adrenoceptor coupling to inositol phosphate formation in rat kidney. Naunyn-Schmiedeberg's Arch Pharmacol 350:592-598
6. 2-adrenergic receptors. FASEB J 6:832-839
7. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR jr, Trendelenburg U (1994) IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 46:121-136
8. Cressier F, Criscione L, Hofbauer KG (1995) Mechanism of interaction between neuropeptide Y and angiotensin II in the rabbit femoral artery. Eur J Pharmacol 272:57-65
9. Fallgren B, Arlock P, Edvinsson L (1993) Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism. J Auton Nerv Syst 44:151-159
10. Folkow B (1982) Physiological aspects of primary hypertension. Physiol Rev 62:347-504
11. 1C subtype. Mol Pharmacol 45:703-708
12. Gehlert DR (1994) Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics. Life Sci 55:551-562
13. Grundemar L, Högestätt ED (1992) Unmasking the vasoconstrictor response to neuropeptide Y and its interaction with vasodilating agents in vitro. Eur J Pharmacol 221:71-76
14. Grundemar L, Jonas SE, Mörner N, Högestätt ED, Wahlestedt C, Hakanson R (1992) Characterization of vascular neuropeptide Y receptors. Br J Pharmacol 105:45-50
15. 1adrenoceptors: consensus update. Pharmacol Rev 47: 267-270
16. Jorgensen JC (1991) Interaction between norepinephrine, NPY and VIP in the ovarian artery. Peptides 12:831-837
17. Kenakin TP (1987) Pharmacological Analysis of Drug-Receptor Interaction. Raven Press, New York
18. Kong J-Q, Taylor DA, Fleming WW (1994) Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat. J Pharmacol Exp Ther 268:1153-1159
19. Larsen PJ, Jukes KE, Chowdrey HS, Lightman SL, Jessop DS (1994) Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinol 134:1634-1639
20. 1A subtype. Mol Pharmacol 46:414-422
21. Michel M.C, Schlicker E, Fink K, Boublik JH, Göthert M, Willette RN, Daly RN, Hieble JP, Rivier JE, Motulsky HJ (1990) Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro. Am J Physiol 259:E131-E139
22. Michel MC (1991) Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci 12:389-394
23. 1-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 348:385-395
24. 2-adrenoceptor subtypes. Mol Pharmacol 44:1165-1170
25. 1-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 350:136-142
26. 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle. Br J Pharmacol 111:539-546
27. Michel MC, Rascher W (1995) Neuropeptide Y - a possible role in hypertension? J Hypertension 13:385-395
28. 1-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 352:1-10
29. 1 receptor/G-protein system in rat brain cortex. Am J Physiol 268:R192-R200
30. 2+. Pharmacol Rev 40:87-119
31. Modin A, Pernow J, Lundberg JM (1991) Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol 203:165-171
32. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41:19-26
33. 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99:197-201
34. 2-adrenoceptors and endothelium-derived relaxing factor. Circ Res 71:188-200
35. 1-adrenoceptor subtypes in rabbit thoracic aorta. Br J Pharmacol 108:1071-1076
36. 2-adrenoceptors in human isolated subcutaneous arteries. Br J Pharmacol 115:1463-1468
37. Ralevic V, Edvinsson L, Burnstock G (1994) Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed. Acta Physiol Scand 151:309-317
38. Ruffolo RR jr, Hieble JP (1994) α-Adrenoceptors. Pharmacol Ther 61:1-64
39. 1A,B-adrenoceptor subtypes in the pithed rat. J Auton Pharmacol 12:125-136
40. Schwinn DA, Johnston GL, Page SO, Mosley MJ, Wilson KH, Worman NP, Campbell S, Roock MO, Furness LM, Parry-Smith DJ, Peter B, Beiley DS (1995) Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species. J Pharmacol Exp Ther 272:134-142
41. Small DL, Bolzon BJ, Cheung DW (1992) Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery. Eur J Pharmacol 210:131-136
42. Tepperman BL, Whittle BJR (1991) Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity. Br J Pharmacol 102:95-100
43. 2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure. Neuropeptides 25:289-298
44. 2-adrenoceptors. Can J Physiol Pharmacol 65:1649-1657
45. Tschöpl M, Miller RC, Pelton J, Stoclet J-C, Bucher B (1993) Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine. Br J Pharmacol 110:1098-1104
46. Wahlestedt C, Reis DJ (1993) Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 32:309-352
47. 1-adrenoceptors mediating vasoconstriction to noradrenalie and nerve stimulation in the isolated perfused mesentery of rat. Br J Pharmacol 114:531-536
48. Xia J, Neild TO, Kotecha N (1992) Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain. Br J Pharmacol 107:771-776